July/August 2020

Loss of smell

Through analysing new data collected through an app, Professor Sebastien Ourselin and colleagues have gained new insights into COVID-19 symptoms. 

Neutralising antibodies against SARS-CoV-2

A trio of papers describe newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV.

The great big biomedical lockdown quiz (part 2)

The second instalment of our biomedical science quiz. This time, we have four experts setting questions to test members’ knowledge across the disciplines.

Experimental cancer blood test

A new method of analysing cancer patients’ blood for evidence of the disease could be up to 10 times more sensitive than previous methods, according to new research.

COVID-19 anti-viral therapy

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

Medical eponyms part 1: Thomas Addison

This is the first article in a series of selected short biographies of persons whose names are directly used for diseases, conditions or syndromes familiar to those working in clinical pathology laboratories. 

COVID-19: a report from Melbourne, Australia

Medical Scientist Eileen Kelly reports on the impact of COVID-19 in Melbourne and the way the pandemic has been dealt with.

CPD awards now open

The Science Council’s CPD Awards are back for 2020 to continue the celebration of outstanding CPD.

IBMS in the pandemic

At a time when biomedical science has never had a more public profile, the IBMS has been working hard in the media and with government to promote the role of its members. IBMS President Allan Wilson explains the measures the institute has taken.

Here to help: an education update

Richardia Penn and Jocelyn Pryce from the IBMS Education Department give an overview of the latest developments. 

Top